Homocysteine, renal function, and risk of cardiovascular disease.

Homocysteine, renal function, and risk of cardiovascular disease.

BACKGROUND: Patients with renal impairment have markedly elevated homocysteine levels and are at particularly high risk of ischemic heart disease (IHD) and stroke, but the relevance of elevated homocysteine levels in this population is uncertain. METHODS: We examined the association with IHD from a...

書目詳細資料
Main Authors:	Clarke, R, Lewington, S, Landray, M
格式:	Journal article
語言:	English
出版:	2003

相似書籍

Homocysteine and risk of cardiovascular disease and venous thrombosis
由: Clarke, R, et al.
出版: (2003)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
由: Clarke, R, et al.
出版: (2007)

Homocysteine and coronary heart disease.
由: Clarke, R, et al.
出版: (2002)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
由: Clarke, R
出版: (2011)

Homocysteine and prediction of coronary heart disease and stroke
由: Clarke, R, et al.
出版: (2003)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
由: Clarke, R, et al.
出版: (2001)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
由: Clarke, R, et al.
出版: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
由: Clarke, R, et al.
出版: (2011)

Homocysteine and cardiovascular disease. Overview.
由: Clarke, R
出版: (1998)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
由: Clarke, R, et al.
出版: (2005)

Renal function: an emerging risk factor for cardiovascular disease?
由: Landray, M, et al.
出版: (2001)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
由: Clarke, R
出版: (2009)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
由: Den Heijer, M, et al.
出版: (2005)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
由: Clarke, R
出版: (2002)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
由: Clarke, R, et al.
出版: (2001)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
由: Clarke, R, et al.
出版: (2007)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk
由: Lewington, S, et al.
出版: (2005)

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
由: Lewington, S, et al.
出版: (2005)

HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
由: Jan Filipovský
出版: (2007-08-01)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
由: Clarke, R, et al.
出版: (2000)

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.
由: Andrew H Ford, et al.
出版: (2012-01-01)

Homocysteine, B vitamins, and cardiovascular disease
由: Refsum, H, et al.
出版: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
由: Refsum, H, et al.
出版: (2006)

Homocysteine, B vitamins, and the risk of dementia.
由: Clarke, R
出版: (2007)

Homocysteine, the kidney, and vascular disease.
由: Haynes, R, et al.
出版: (2012)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
由: Haynes, R, et al.
出版: (2012)

Elevated homocysteine and differential risks of the renal function decline in hypertensive patients
由: Chunlei Liu, et al.
出版: (2020-08-01)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
由: Ueland, P, et al.
出版: (2007)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
由: Danesh, J, et al.
出版: (1998)

Uncontrolled hypertension and risk of cardiovascular mortality in China-reply
由: Lewington, S, et al.
出版: (2016)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
由: Clarke, R, et al.
出版: (1998)

Homocysteine-lowering trials for prevention of heart disease and stroke.
由: Clarke, R
出版: (2005)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
由: Holman, R, et al.
出版: (2001)

Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?
由: Swiss Medical Weekly
出版: (2006-12-01)

Homocysteine and malondialdeyde (MDA) levels associated with the occurrence of cardiovascular disease (CVD) in chronic renal failure (CRF) in Malaysia.
由: Arab, Shahin, et al.
出版: (2011)

Detecting homocysteine in cardiovascular disease using aptasensors: A review
由: Sara Ranjbari, et al.
出版: (2023-12-01)

Which cardiovascular risk factors matter in chronic kidney disease?
由: Baigent, C, et al.
出版: (2007)

The influence of total physical inactivity on plasma homocysteine levels. Risk factor for development of cardiovascular disease
由: Mihaela Jurdana, et al.
出版: (2009-06-01)

The Effects of Smokeless Tobacco "Maras Powder" on Homocysteine and Cardiovascular Risk Parameters
由: Gülizar Sökmen, et al.
出版: (2023-06-01)

Folic acid enhances the cardiovascular protective effect of amlodipine in renal hypertensive rats with elevated homocysteine
由: Li Li, et al.
出版: (2023-12-01)